GlassScriptPhysician profile
Megan Nichoalds
NPI 1962832980
$1,284.75
in general payments reported to CMS, 2019-2025
20 companies · $35.42 in 2025
The $35.42 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $451 · 2023: $678 · 2025: $35.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $490.52 | 2021-2025 | |
| Lilly USA, LLC | $178.88 | 2021-2023 | Mounjaro, Emgality, Jardiance |
| Novo Nordisk INC | $75.26 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Otsuka America Pharmaceutical, INC. | $51.43 | 2022-2023 | Rexulti |
| Corium, LLC | $51.43 | 2023 | Azstarys |
| Glaxosmithkline, LLC. | $47.98 | 2022-2023 | Shingrix, Bexsero, Arexvy |
| Pfizer INC. | $43.44 | 2023 | |
| Medtronic, INC. | $38.05 | 2022 | |
| Axsome Therapeutics, INC. | $37.23 | 2023 | Auvelity |
| Exact Sciences Corporation | $36.68 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $36.14 | 2023 | Quviviq |
| Amgen INC. | $30.58 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.20 | 2022-2023 | Breztri |
| Nevro Corp. | $23.93 | 2023 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $23.89 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.33 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.42 | 2023 | Trintellix |
| Abbott Laboratories | $18.03 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.86 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Nichoalds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.